U.S. market Open. Closes in 4 hours 44 minutes

ETNB | 89bio, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
RevenueN/AN/AN/AN/AN/AN/A
Cost of Revenue273.00K240.00K79.00K60.00K17.00KN/A
Gross Profit-273.00K-240.00K-79.00K-60.00K-17.00KN/A
Operating Expenses144.96M102.25M89.74M49.35M26.64M15.16M
Selling, General & Admin28.97M21.45M19.41M13.16M5.29M1.48M
Research & Development122.23M80.80M70.33M36.20M21.35M13.68M
Other Operating ExpensesN/A242.00K-526.00K-203.00K-30.56M-986.00K
Operating Income-151.20M102.25M-89.74M-49.35M-26.64M-15.16M
Other Expenses / Income12.88M-204.26M-526.00K-203.00K-30.56M-986.00K
Before Tax Income-138.32M-102.01M-90.27M-49.56M-57.20M-16.15M
Income Tax Expenses3.87M19.00K-147.00K-59.00K218.00K28.00K
Net Income-142.19M-102.03M-90.12M-49.50M-57.42M-16.18M
Interest Expenses3.59M1.92M674.00KN/AN/AN/A
Basic Shares Outstanding71.17M34.81M20.10M16.09M2.34M4.58M
Diluted Shares Outstanding71.17M34.81M20.10M16.09M2.34M4.58M
EBITDA-151.15M-102.25M-89.74M-49.35M-26.64M-15.16M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-134.74M-100.08M-89.59M-49.56M-57.20M-16.15M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙